EV-077

N/A

Report date: 2023/12/04 20:05:36
NME

Base Information

Drug NameEV-077
Drug Alias NameEV-077-3201-2TBSEV-077-3201-2EV-077-3201-2TBSER-150-TBSSER-150DN +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsThromboxane A2 receptor antagonists
TargetsThromboxane A2 synthaseThromboxane A2 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustraliaGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvolva
China Registration ClassN/A

Develop Information

Active CompaniesSerodus AS
Inactive CompaniesEvolva Sa
Active IndicationsDiabetic Nephropathies
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A